Ureteral Stents Market Size To Reach $1,108.3 Million By 2033

July 2026 | Report Format: Electronic (PDF)

Ureteral Stents Market Growth & Trends

The global ureteral stents market size is expected to reach USD 1,108.3 million by 2033, registering a CAGR of 6.3% from 2026 to 2033, according to a new report by Grand View Research, Inc. Rising incidence of urological diseases such as kidney stones, urinary incontinence, tumors is driving the market. Ureteral stents help in restoring the flow of urine through the blocked ureters and are utilized during urological surgeries to maintain the patency of the ureter. These are used for several medical conditions such as kidney stones, urinary incontinence, and kidney transplants. Thus, with the mounting prevalence of these incidences, the market is anticipated to witness a significant growth rate over the forecast period.

In addition, the geriatric population is at higher risk to develop urological and kidney-related issues such as kidney stones. Thus, the growing geriatric population is expected to drive the market. For instance, as per the WHO report 2018, the world base of population pertaining to the age group of 60 and above is anticipated to reach 2.0 billion by 2050 from 900.0 million in 2015. This is expected to propel market growth over the forecast period.

Furthermore, the incorporation of new technologies and introduction of new products by market players are expected to boost the market growth. For instance, in 2019, Boston Scientific has unveiled the LithoVue Empower retrieval deployment device which is utilized with company’s single-use digital flexible ureteroscope during kidney stone retrieval procedures.

Request a free sample copy or view report summary: Ureteral Stents Market Report

Ureteral Stents Market Report Highlights

By material type, the polymer ureteral stents held the largest revenue share of 65.4% in 2025. The metallic stents segment is expected to grow at a significant CAGR during the forecast period.
By type, the double J stents held the largest revenue share of 71.1% in 2025. The multiloop stents segment is expected to grow at the fastest CAGR during the forecast period.
By coating, the uncoated segment held the largest revenue share of 54.7% in 2025. The coated segment is expected to grow at the fastest CAGR during the forecast period
By application, the kidney stones held the largest revenue share of 36.3% in 2025. The urinary incontinence segment is expected to grow at a significant CAGR during the forecast period.
By end-use, the hospitals held the largest revenue share of 67.4% in 2025. The Ambulatory Surgery Centers (ASCs) segment is expected to grow at the fastest CAGR during the forecast period.